Ontology highlight
ABSTRACT: Background
A few studies in the last several years have shown that metabolomics, the study of metabolites and small intermediate molecules, may help better understand the breast carcinogenesis. However, breast cancer is a heterogeneous disease with different subtypes. Additionally, there is a significant racial difference in terms of breast cancer incidence and mortality. Few, if any, metabolomics studies in breast cancer have considered race and tumor subtypes in the study design.Methods
We performed a global metabolomic profiling using mass spectrometry and samples from 60 breast cancer cases and 60 matched controls.Results
A total of 375 named metabolites were observed, with 117 metabolites whose levels were significantly different between African American and Ca
SUBMITTER: Shen J
PROVIDER: S-EPMC3890711 | biostudies-literature | 2013 Dec
REPOSITORIES: biostudies-literature